4G: Tissue Engineering SIG 2
Time: 1:30 PM to 3:30 PM
Description
Tissue Engineering SIG is a forum to exchange information, further knowledge, and promote greater awareness regarding all aspects of the use of biomaterials to engineering tissue substitutes or to promote tissue regeneration. Of primary interest and relevance to TE SIG is the use of appropriate materials (synthetic and natural) with cells (either native or from a donor source) and/or biological response modifiers (e.g., growth factors, cytokines and other recombinant products) to replace tissue and organ functions. Particular emphasis is placed on the development of materials to better incorporate, protect, and deliver both the cells and biological response modifiers to help promote the healing and regenerative processes. The group is committed to forging interactions among basic scientists, applied scientists, engineers, clinicians, industrial members, professional societies in related fields, and regulatory groups in its efforts to expand and effectively utilize the shared knowledge base in this multidisciplinary field.
Moderators:
Jeannine Coburn, Worcester Polytechnic Institute
Gulden CamciUnal, Univeristy of Massachusetts Lowell
Qun Wang, Iowa State University
Objectives
1:30 PM. 189. Amphiregulin releasing alginate hydrogels for treating ischemic muscle injuries.Brennagh Shields1, Lauren Mottel1, Lindsay Gallagher1, Brian Kwee1 1University of Delaware
1:45 PM. 190. Decellularized Lucky Bamboo Scaffolds as Platforms for Bone Tissue Engineering.Ali Salifu1, Precious Etinosa2, Vanessa Uzonwanne1, Joshua Gershlak3, John Obayemi2, Glenn Gaudette1, Wole Soboyejo2 1Boston College, 2Worcester Polytechnic Institute, 3Massachusetts General Hospital
2:00 PM. 191. Hydrogel-Delivery of hiPSC-Cortical Neurons Improves Local and Distal Anatomical and Functional Outcomes Following Chronic Cervical Spinal Cord Injury.Vanessa Doulames, PhD1, Meghan Hefferon, BS1, Neil Baugh1, Christopher Long1, Michelle Huang1, Theo Palmer, PhD2, Sarah Heilshorn, PhD1 1Stanford University, 2Stanford University School of Medicine
2:15 PM. 192. Magneto-Responsive Iron-Chelated Silk Microfibers as an In-Situ Aligning Architecture for Injectable Biomaterials.Melissa Wojnowski, MS1, Jeannine Coburn, PhD1 1Worcester Polytechnic Institute
2:30 PM. 193. Rapid Fabrication of Polyvinyl Alcohol Hydrogel Foams with Encapsulated Mesenchymal Stem Cells for Chronic Wound Treatment.Nghia Le Ba Thai1, Emily Fittante1, Zhen Ma2, Mary Beth Monroe, PhD2 1BioInspired Syracuse, Syracuse University, 2Syracuse University
2:45 PM. 194. Self-organized insulin-producing β-cells differentiated from human omentum-derived stem cells and their in vivo therapeutic potential.Ji Hoon Jeong, Ph.D.1, Yongsung Hwang, Ph.D.1, Joohyun Kim, Ph.D.1, Ki Nam Park, Ph.D.2, Sang-Heon Kim, Ph.D.3, Jae Hong Park, Ph.D.4, Sung Sik Hur, Ph.D.1 1Soonchunhyang institute of medi-bio science, 2Soonchunhyang University Bucheon Hospital, 3Korea Institute of Science and Technology, 4Soonchunhyang University Cheonan Hospital
3:00 PM. 195. Use of an Injectable Recombinant Polypeptide Scaffold for Peripheral Nerve Repair.Rachael Putman1, Stefan Roberts, PhD2, Daniel Joh, MD, PhD1, Neill Li, MD1, Ashutosh Chilkoti, PhD1 1Duke, 2inSoma Bio; Duke
3:15 PM. 196. WNT7A mRNA-LNPs Reduce Skeletal Muscle Fibro-adipogenic Progenitor Adipogenesis.Larion Martin Santiago1, Kasoorelope Oguntuyo1, Britney Chin-Young1, Angelo Amabile, PhD1, Woojin Han1 1Icahn School of Medicine at Mount Sinai